Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

2.

More People Than Previously Believed Have Schizophrenia.

3.

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

4.

Radioactive ion beams successfully treat animal tumors in study

5.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot